AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail
March 16, 2021 at 06:35 AM EDT
AZD7442 is being evaluated for the prevention and treatment of COVID-19 in late-stage trials in more than 9,000 participants around the world.
